Eurican DAP inj. susp. (lyoph. + solv.) s.c. vial

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Canine Parvovirus (live, attenuated) ; Canine Distemper Virus (live, attenuated) ; Canine Adenovirus 2 (live, attenuated)

MAH:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATC_code:

QI07AD02

INN:

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

pharmaceutical_form:

Lyophilisate and solvent for suspension for injection

composition:

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

administration_route:

Subcutaneous use

therapeutic_group:

dog

therapeutic_area:

Canine Distemper Virus + Canine Adenovirus + Canine Parvovirus

leaflet_short:

CTI code: 499155-01 - Pack size: 10 x 1 dose + 10 x 1 ml - Commercialisation status: YES - FMD code: 03661103053590 - CNK code: 3495041 - Delivery mode: Medical prescription; CTI code: 499155-03 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 499155-02 - Pack size: 50 x 1 dose + 50 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

2016-07-04